ClinicalTrialsFinder

HER2/Neu-Negative Breast Cancer Clinical Trials in Chicago, Illinois

1 recruitingChicago, Illinois

Showing 1–1 of 1 trials

Recruiting
Phase 2

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Metastatic Breast CancerEstrogen Receptor-positive Breast CancerHER2/Neu-Negative Breast Cancer+1 more
Northwestern University174 enrolled1 locationNCT06062498